PSQ Stock Overview
Pacific Smiles Group Limited, together with its subsidiaries, owns and operates dental centers under the Pacific Smiles Dental Centres and nib Dental Care Centres names in Eastern Australia.
No risks detected for PSQ from our risk checks.
Pacific Smiles Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$1.49|
|52 Week High||AU$3.08|
|52 Week Low||AU$1.35|
|1 Month Change||2.76%|
|3 Month Change||-16.53%|
|1 Year Change||-45.22%|
|3 Year Change||-3.87%|
|5 Year Change||-23.20%|
|Change since IPO||-16.29%|
Recent News & Updates
|PSQ||AU Healthcare||AU Market|
Return vs Industry: PSQ underperformed the Australian Healthcare industry which returned -20.4% over the past year.
Return vs Market: PSQ underperformed the Australian Market which returned -10.8% over the past year.
|PSQ Average Weekly Movement||5.1%|
|Healthcare Industry Average Movement||5.4%|
|Market Average Movement||9.4%|
|10% most volatile stocks in AU Market||16.5%|
|10% least volatile stocks in AU Market||4.2%|
Stable Share Price: PSQ is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: PSQ's weekly volatility (5%) has been stable over the past year.
About the Company
Pacific Smiles Group Limited, together with its subsidiaries, owns and operates dental centers under the Pacific Smiles Dental Centres and nib Dental Care Centres names in Eastern Australia. It provides services and equipped facilities to dentists, including support staff, materials, marketing, and administrative services. The company also offers dental services, such as cosmetic dentistry, child dental care, dental check-ups, emergency dental, endodontics, gum disease treatment, Invisalign, orthodontics, periodontics, prosthodontics, root canal treatment, sleep dentistry, teeth cleaning, teeth whitening, tele dentistry, tooth extraction, and wisdom teeth removal, as well as offers dental crowns, dental implants, dentures, veneers, and SmileStyler clear aligners.
Pacific Smiles Group Fundamentals Summary
|PSQ fundamental statistics|
Is PSQ overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|PSQ income statement (TTM)|
|Cost of Revenue||AU$79.43m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.028|
|Net Profit Margin||-3.25%|
How did PSQ perform over the long term?See historical performance and comparison
Is PSQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PSQ?
Other financial metrics that can be useful for relative valuation.
|What is PSQ's n/a Ratio?|
Price to Sales Ratio vs Peers
How does PSQ's PS Ratio compare to its peers?
|PSQ PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
MVF Monash IVF Group
EHE Estia Health
REG Regis Healthcare
PGC Paragon Care
PSQ Pacific Smiles Group
Price-To-Sales vs Peers: PSQ is expensive based on its Price-To-Sales Ratio (1.7x) compared to the peer average (1x).
Price to Earnings Ratio vs Industry
How does PSQ's PE Ratio compare vs other companies in the AU Healthcare Industry?
Price-To-Sales vs Industry: PSQ is expensive based on its Price-To-Sales Ratio (1.7x) compared to the Australian Healthcare industry average (1.2x)
Price to Sales Ratio vs Fair Ratio
What is PSQ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||1.7x|
|Fair PS Ratio||2.8x|
Price-To-Sales vs Fair Ratio: PSQ is good value based on its Price-To-Sales Ratio (1.7x) compared to the estimated Fair Price-To-Sales Ratio (2.8x).
Share Price vs Fair Value
What is the Fair Price of PSQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PSQ (A$1.49) is trading below our estimate of fair value (A$2.58)
Significantly Below Fair Value: PSQ is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
How is Pacific Smiles Group forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Future Growth Score5/6
Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PSQ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).
Earnings vs Market: PSQ is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PSQ is expected to become profitable in the next 3 years.
Revenue vs Market: PSQ's revenue (16.9% per year) is forecast to grow faster than the Australian market (3.7% per year).
High Growth Revenue: PSQ's revenue (16.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PSQ's Return on Equity is forecast to be high in 3 years time (21.6%)
Discover growth companies
How has Pacific Smiles Group performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PSQ is currently unprofitable.
Growing Profit Margin: PSQ is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: PSQ is unprofitable, and losses have increased over the past 5 years at a rate of 14.2% per year.
Accelerating Growth: Unable to compare PSQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PSQ is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-7.9%).
Return on Equity
High ROE: PSQ has a negative Return on Equity (-7.69%), as it is currently unprofitable.
Discover strong past performing companies
How is Pacific Smiles Group's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: PSQ's short term assets (A$24.4M) do not cover its short term liabilities (A$34.9M).
Long Term Liabilities: PSQ's short term assets (A$24.4M) do not cover its long term liabilities (A$96.7M).
Debt to Equity History and Analysis
Debt Level: PSQ's net debt to equity ratio (11.4%) is considered satisfactory.
Reducing Debt: PSQ's debt to equity ratio has increased from 11.4% to 31.4% over the past 5 years.
Debt Coverage: PSQ's debt is well covered by operating cash flow (96.7%).
Interest Coverage: Insufficient data to determine if PSQ's interest payments on its debt are well covered by EBIT.
Discover healthy companies
What is Pacific Smiles Group current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Forecast Dividend Yield
Dividend Yield vs Market
|Pacific Smiles Group Dividend Yield vs Market|
|Company (Pacific Smiles Group)||0%|
|Market Bottom 25% (AU)||2.8%|
|Market Top 25% (AU)||7.2%|
|Industry Average (Healthcare)||2.9%|
|Analyst forecast in 3 Years (Pacific Smiles Group)||3.1%|
Notable Dividend: Unable to evaluate PSQ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PSQ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PSQ's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PSQ's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: PSQ is not paying a notable dividend for the Australian market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PSQ has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Philip McKenzie, also known as Phil, has been Managing Director, Chief Executive Officer and Executive Director at Pacific Smiles Group Limited since October 29, 2018. He is Chief Executive Officer of...
CEO Compensation Analysis
|Phil McKenzie's Compensation vs Pacific Smiles Group Earnings|
|Date||Total Comp.||Salary||Company Earnings|
|Jun 30 2022||AU$1m||AU$590k|
|Mar 31 2022||n/a||n/a|
|Dec 31 2021||n/a||n/a|
|Sep 30 2021||n/a||n/a|
|Jun 30 2021||AU$1m||AU$625k|
|Mar 31 2021||n/a||n/a|
|Dec 31 2020||n/a||n/a|
|Sep 30 2020||n/a||n/a|
|Jun 30 2020||AU$741k||AU$506k|
|Mar 31 2020||n/a||n/a|
|Dec 31 2019||n/a||n/a|
|Sep 30 2019||n/a||n/a|
|Jun 30 2019||AU$551k||AU$332k|
Compensation vs Market: Phil's total compensation ($USD687.94K) is about average for companies of similar size in the Australian market ($USD618.04K).
Compensation vs Earnings: Phil's compensation has been consistent with company performance over the past year.
Experienced Management: PSQ's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.
Experienced Board: PSQ's board of directors are considered experienced (3.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
|06 Jun 22||BuyAU$4,172,304||Moelis Australia Asset Management Ltd||Company||2,055,209||AU$2.03|
|16 May 22||BuyAU$3,768,988||Ice Investors Pty Ltd||Company||1,815,082||AU$2.40|
|13 Dec 21||BuyAU$41,919,988||HBF Health Limited, Asset Mnagement Arm||Company||16,000,000||AU$2.62|
|15 Nov 21||SellAU$1,160,149||Moelis Australia Asset Management Ltd||Company||400,000||AU$2.90|
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Pacific Smiles Group Limited's employee growth, exchange listings and data sources
- Name: Pacific Smiles Group Limited
- Ticker: PSQ
- Exchange: ASX
- Founded: 2002
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: AU$237.777m
- Shares outstanding: 159.58m
- Website: https://pacificsmilesgroup.com.au
Number of Employees
- Pacific Smiles Group Limited
- 6 Molly Morgan Drive
- Level 1
- East Maitland
- New South Wales
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PSQ||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Nov 2014|
|PSQ||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Nov 2014|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/10/01 00:00|
|End of Day Share Price||2022/09/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.